Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018

Abstract Randomised controlled trials have shown a neutral or even unfavourable risk–benefit balance of aspirin for primary prevention of cardiovascular events. Using Danish nationwide registries, we investigated aspirin use and associated risks during the past two decades (1998–2018). We linked ind...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mikkel B. Christensen, Espen Jimenez-Solem, Martin. T. Ernst, Morten Schmidt, Anton Pottegård, Erik L. Grove
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/b2be06933ec84314ab22e613f81050c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares